Hepatocellular carcinoma (HCC) is an aggressive disease with a poor clinical outcome. The
cancer stem cell (CSC) model states that tumour growth is powered by a subset of tumour …

Liver cancer is an often fatal malignant tumor with a high recurrence rate and
chemoresistance. The major malignant phenotypes of cancer, including recurrence …

Abstract N 6-methyladenosine (m6A) RNA methylation contributes to the cancer stem cell
(CSC) phenotype through regulating gene expression. YTHDF2, an m6A reader, was shown …

Glucose metabolism reprogramming, which is a well‐established characteristic of multiple
cancers, demands a higher rate of glycolysis to meet the increasing demands for …

Liver tumour-initiating cells (TICs) contribute to tumour initiation, metastasis, progression
and drug resistance. Metabolic reprogramming is a cancer hallmark and plays vital roles in …

Abstract Background N 6-methyladenosine (m 6 A) emerges as one of the most important
modification of RNA. Bladder cancer is a common cancer type in developed countries, and …

Liver cancer stem cells (CSCs) may contribute to the high rate of recurrence and
heterogeneity of hepatocellular carcinoma (HCC). However, the biology of hepatic CSCs …

Background Hepatocellular carcinoma (HCC) is an aggressive malignant disease with poor
prognosis. Recent advances suggest the existence of cancer stem cells (CSCs) within liver …

Tumor‐associated neutrophils (TANs) play a crucial role in tumor development and
progression in the cancer microenvironment. Despite increased understanding of TAN …

Hepatocellular carcinoma (HCC) is the most prevalent liver cancer, characterized by a high
rate of recurrence and heterogeneity. Liver cancer stem cells (CSCs) may well contribute to …